NEW YORK (GenomeWeb News) – Shimadzu and the University of Tokyo today announced a collaboration to develop technologies aimed at lipidomic biomarkers.
The deal, which extends until March 31, 2014, calls for the company and the school to perform joint research in topics such as the development of a biological sample pretreatment system and developing a comprehensive method for analyzing functional, membrane, and other lipids, and then applying them to the discovery of lipid biomarkers that may be associated with various diseases, including those related to lifestyles.
Shimadzu, the University of Tokyo, and Ono Pharmaceutical jointly established a sponsored laboratory within the department of lipidomics in the Graduate School of Medicine and Faculty of Medicine at the university in April in order to enable studies into low molecular weight compounds, such as bioactive and membrane lipids, "as the next area of research following genomics and proteomics," the partners said.
The parties signed the agreement last month but didn't announce it until today. Financial details were not disclosed.